Nevro Corp. (NVRO) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Painful Diabetic Neuropathy
04M8M11M15M19M22M26M30MQ4 2023

Revenue by Geography

UNITED STATESNon-US
038M75M112M150M188M225M262M300MQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
038M75M112M150M188M225M262M300MQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Margin (%)

Gross MarginOperating MarginNet Income Margin
01020304050607080Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
025M50M75M100M125M150M175M200MQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024

EBITDA

EBITDA
-50M-44M-37M-31M-25M-19M-12M-6M1Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024

EPS

Revenue Variation (%)

Revenue Variation
-20-15-10-505101520Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
075150225300375450525600Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Revenue YoY Variation (%)

Revenue YoY Variation
-20-17-13-10-6-3047Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
01252503755006257508751KQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Price-to-Earning Ratio

P/E Ratio
-30-26-22-18-14-11-7-31Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
02M5M8M10M12M15M18M20MQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
001222344Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
06M12M19M25M31M38M44M50MQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Free Cash Flow

Cash At End Of Period
025M50M75M100M125M150M175M200MQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
09M18M26M35M44M52M61M70MQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024
🏦 Balance Sheet
📈 Key Metrics